Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Hydroxyzine pamoate - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydroxyzine pamoate and what is the scope of hydroxyzine pamoate freedom to operate?

Hydroxyzine pamoate
is the generic ingredient in three branded drugs marketed by Watson Labs, Heritage Pharma, Teva, Sandoz, Superpharm, Par Pharm, Impax Labs Inc, Pfizer, Ivax Sub Teva Pharms, Barr, Vangard, and Duramed Pharms Barr, and is included in thirty-seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for hydroxyzine pamoate. Thirty-six suppliers are listed for this compound.

Summary for Generic Name: hydroxyzine pamoate

Drug Master File Entries: see list19
Suppliers / Packagers: see list36
Bulk Api Vendors: see list26
Clinical Trials: see list9
Patent Applications: see list1,279
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydroxyzine pamoate at DailyMed

Pharmacology for Ingredient: hydroxyzine pamoate

Drug ClassAntihistamine
Mechanism of ActionHistamine Receptor Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
hydroxyzine pamoate
CAPSULE;ORAL089033-001Jan 2, 1987DISCNNoNo► Subscribe► Subscribe
Duramed Pharms Barr
hydroxyzine pamoate
CAPSULE;ORAL088594-001Feb 29, 1984DISCNNoNo► Subscribe► Subscribe
Heritage Pharma
hydroxyzine pamoate
CAPSULE;ORAL201507-002Jun 3, 2013ABRXNoNo► Subscribe► Subscribe
Par Pharm
hydroxyzine pamoate
CAPSULE;ORAL087658-001Jun 11, 1982DISCNNoNo► Subscribe► Subscribe
Par Pharm
hydroxyzine pamoate
CAPSULE;ORAL089146-001Mar 17, 1986DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus